Lipa continues to provide cream and gel manufacturing services from its primary site in Minto, but the acquisition of Quest Pharmaceuticals in Melbourne has further enhanced Lipa’s capability and capacity to provide a range of additional cream and gel dosage formats. Both sites are fully approved to provide a range of cosmetic, listed and registered cream and gel products and increasingly provide our existing customer base with a range of new and innovative product formulations and dosage formats. The acquisition of the Quest Pharmaceuticals business has enabled Lipa to expand this area of our operations at a substantially faster and more effective manner.
熱門標(biāo)簽
2006-2024 上海博華國際展覽有限公司版權(quán)所有（保留一切權(quán)利）
滬ICP備05034851號-111
滬公網(wǎng)安備 31010402000558號
